<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00632450</url>
  </required_header>
  <id_info>
    <org_study_id>40004879</org_study_id>
    <nct_id>NCT00632450</nct_id>
  </id_info>
  <brief_title>EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study</brief_title>
  <acronym>EnSite RT CPM</acronym>
  <official_title>EnSite Real-Time Cardiac Performance Measurements Study, a Non-significant Risk Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter,
      international, acute, non-significant risk study, designed to enroll a maximum of 40 patient.
      The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping
      system during a CRT implant.

      Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite
      NavX Mapping system during the implantation of a cardiac resynchronization therapy device.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for implantation of a CRT pulse generator
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be undergoing a new St. Jude Medical CRT-D or CRT-P device implantation

          -  Have the ability to provide informed consent for study participation and be willing to
             comply with the prescribed perioperative evaluations

        Exclusion Criteria:

          -  Have a recent myocardial infarction within 40 days prior to enrollment

          -  Have undergone cardiac surgery or coronary revascularization procedure within 3 months
             prior to enrollment or be scheduled for such procedures

          -  Be less than 18 years of age

          -  Be pregnant women

          -  Be currently participating in a clinical study that includes an active treatment arm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes Sperzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff Klinik GmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andre d'Avila, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Imran Niazi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arrhythmia Center of Southern Wisconsin, Ltd</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Jude Medical</name>
      <address>
        <city>Sunnyvale</city>
        <state>California</state>
        <zip>94086</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 29, 2008</study_first_submitted>
  <study_first_submitted_qc>March 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2008</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

